Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.18−0.26 (-3.08%)
Close on Nov 13, 2026Market cap $740.81MP/E –Yield –
Verastem enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Verastem's enterprise value was $686.08M on Nov 11, 2026, against $572.51M a year earlier. Over the last 5 years it ranged from -$72.57M to $745.80M, with a median of $131.16M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $686.08M | +81.7% |
| 2025 | Dec 31, 2025 | $377.60M | +297.7% |
| 2024 | Dec 31, 2024 | $94.95M | +137.6% |
| 2023 | Dec 29, 2023 | $39.96M | – |
| 2022 | Dec 30, 2022 | -$19.97M | -107.4% |
| 2021 | Dec 31, 2021 | $270.03M | +73.7% |
| 2020 | Dec 31, 2020 | $155.43M | – |
| 2019 | Dec 31, 2019 | -$60.62M | -147.7% |
| 2018 | Dec 31, 2018 | $127.11M | +96.4% |
| 2017 | Dec 29, 2017 | $64.71M | – |
| 2016 | Dec 30, 2016 | -$45.45M | – |
| 2015 | Dec 31, 2015 | -$51.77M | -136.2% |
| 2014 | Dec 31, 2014 | $143.16M | -23.7% |
| 2013 | Dec 31, 2013 | $187.51M | +34.0% |
| 2012 | Dec 31, 2012 | $139.98M | – |
See a number that looks wrong?